Repeat Testing Interval for Normal PAP with Positive HPV

Management Algorithm

For a patient with a normal PAP smear but positive high-risk HPV test, the Centers for Disease Control and Prevention recommends repeat HPV testing with or without concurrent PAP should be performed in 1 year 1, 2
If HPV genotyping shows HPV 16 or 18, the American Society for Colposcopy and Cervical Pathology recommends proceeding directly to colposcopy regardless of normal cytology, as these genotypes carry the highest risk for CIN 3+ 1, 3
If HPV type is non-16/18 high-risk, the Centers for Disease Control and Prevention recommends return in 1 year for repeat testing 1

The preferred approach is HPV testing with or without concurrent PAP, rather than cytology alone, as HPV testing is less likely to miss disease 1, 2
At the 1-year follow-up visit, if both tests are negative, the American College of Obstetricians and Gynecologists recommends return to routine 3-year screening intervals 1, 4
If HPV remains positive or cytology is abnormal, the American Society for Colposcopy and Cervical Pathology recommends referral for colposcopy 1, 2

The 2021 CDC STI Treatment Guidelines and 2019 ASCCP Risk-Based Management Consensus Guidelines both specify that women with normal cytology but positive high-risk HPV should be retested at 1 year 1, 2
Risk stratification shows that a single HPV-positive result with normal cytology in women with recent negative screening history carries lower immediate risk for CIN 3+ 1, 2
Many HPV infections clear spontaneously within 12-24 months, particularly in younger women 1
Persistent HPV positivity at 1 year significantly elevates risk and warrants colposcopy 1

If the patient had a negative HPV test or cotest within the previous 5 years before this current positive result, the risk is lower and 1-year follow-up is appropriate 1, 2